AzTrials
AzTrials

Functional Brain MappingPhase 1TAPFINGERNCT02574026

Tapfinger Psychomotor Target

A Phase 1 study testing Psychomotor tasks in people with Functional Brain Mapping, run by University Hospital, Grenoble at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims at mapping the magnetoencephalographic (MEG) activities induced in normal volunteers by tapping the finger . Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Functional Brain Mapping
What is being tested?
Psychomotor tasks
Could I receive a placebo?
No, everyone receives an active treatment
How many people
37 participants
Where
1 siteFrance
Study dates
Aug 2010to 31 Jul 2020
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male or Female between 18 and 70 years
  • Informed consent
  • Benefiting from Social Security
  • French or english speaking, to understand study procedure
  • Tetraplegic patients : traumatic injury of the cervical spine with retained respiratory autonomy and without associated head injury

Who cannot join

  • Contra-indication to MRI
  • Claustrophobia
  • Mental disorders
  • Pregancy
  • All categories of protected persons

Trial locations and contacts

1 site in 1 country.

France1 site
  • CLINATEC

    Grenoble, 38000

Other trials in France

About this study

Official title: MagnetoEncephaloGraphy Study of Cerebral Activations Induced by Psychomotor Tasks for Target Localisation in View of BCI Clinical Trial

The study aims at mapping the magnetoencephalographic (MEG) activities induced in normal volunteers by tapping the finger .

Read the detailed description

Normal healthy (20) volunteers and tetraplegic patients(10) will be submitted to the temporo-spatial mapping of their brain activity, both sensory and motor, induced by a simple behavioral task, consisting on tapping with the finger on a detection pad. This will be done in a light and then dark environment, on a rythm spontaneous and then paced by sound bips. Accelerometric recording will provide the three dimensionnal displacements of the finger as well as the time code.

Brain activity is simultaneously recorded using MEG (306 channels) and EEG (64 channels. Data will be processed by an INPLS algorithm to detect the predictors of activity, their location and time-course.

3D mapping data will be matched with the patient's anatomy provided by 1.5T MRI previously performed.

The aim of the study is to prepare the strategy of implantation of multielectrodes ECoG implants to restore motility in tetraplegic patients in a human BCI protocol currently under development.

Being tested
Psychomotor tasks
Keywords
MEG, EEG, MRI, Brain mapping, functional imaging, brain computer interface

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychomotor tasksBehavioural

    the acquisition of data will be performed in one unique session no drug administration no surgery

Study groups in NCT02574026
Study groupRoleWhat they receive
Psychomotor tasksExperimental20 healthy subjects and 10 tetraplegic patients will participate to acquisition of MEG, EEG, MRI data during a motor tasks
Receives: Behavioral: Psychomotor tasks

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. MEG records for functional brain mapping

    This study is not a therapeutic clinical study. No treatment is being delivered.

    Measured: one hour study

Secondary outcomes (2)
  1. MEG measurements during psychomotor tasks

    MEG records induced by finger tapping will be performed either randomly or following sound bips pacing.

    Measured: one hour study

  2. EEG measurements during psychomotor tasks

    EEG records induced by finger tapping will be performed either randomly or following sound bips pacing.

    Measured: one hour study

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Oct 2015 (estimated)
  2. Study startAug 2010
  3. Primary completion31 Jul 2020
  4. Study completion31 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
37 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02574026
Sponsor's protocol ID
2010-A00421-38
Acronym
TAPFINGER
Status last verified
May 2022
First submitted
5 Oct 2015
Last updated
24 May 2022
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Psychomotor tasks in people with Functional Brain Mapping, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

MEG records for functional brain mapping (time frame: one hour study). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 May 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in